News
Stay Up-To-Date on NEXT Oncology
- All
- NEXT Oncology Blog
- NEXT Oncology News
- Press Releases
Machine Learning in the Diagnosis of Gastric Cancer and Pulmonary Nodule Workup
Machine learning algorithms are increasingly being applied across different areas of medicine and oncology to analyze large data sets and draw conclusions that may otherwise escape the human eye. Indeed, …
Worldwide Clinical Trials Expands Site Alliance Collaboration to Support Oncology Trials
RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–In response to the growing and ever-changing clinical research landscape and the need to bring innovative treatments to patients faster, Worldwide Clinical Trials (Worldwide), a leading global, full-service …
NEXT Oncology is the perfect place to compassionately improve outcomes for patients with cancer, now and in the future.
“Cancer has no geographic boundaries,” said Dr. Tolcher, CEO and founder of NEXT Oncology. “One of the continuing challenges has been that cancer research has been conducted in silos. Our goal …
Drug Development in Gastric Cancer: Are We at an Inflection Point?
Gastric cancer drug development has long been thwarted by the challenges of identifying effective targets and developing drugs against the backdrop of the cancer’s inherent tumor heterogeneity.1 Recently, however, advances in …
Update on Conservative Management of the Axilla when the Sentinel Node is Positive in Breast cancer.
Research remains an essential part of cancer care. In this blog, we will provide information about recent updates or new approvals as it applies to breast cancer written by Dr. …
ABM Announces First Patient Dosed in Phase I Clinical Trial of MEK Inhibitor for Solid Tumor
SAN DIEGO and SHANGHAI, May 5, 2023 /PRNewswire/ — ABM Therapeutics, an innovative clinical-stage biopharmaceutical company, with an emphasis on developing drugs with high blood–brain barrier (BBB) penetration for CNS diseases including brain metastases, …
Video: Expanded Phase 1 Program to the Dallas Area
In this video hosted by Oncology Tube, Anthony Tolcher, MD, discusses Cancer Drug Research: Expanded Phase 1 Program to the Dallas Area. iFrame is not supported!
SA cancer research company entering Dallas market as it eyes more U.S., European expansion
A cancer research company based in San Antonio is entering the Dallas market as it eyes more U.S. and European expansion… Read the full article at the San Antonio Business …
First Report of Positive Dose Escalation Data Supports Best-in-Class Profile for Investigational Exarafenib as a Single Agent and in Combination with Binimetinib in BRAF-altered Cancers and NRAS Mutant Melanoma
SAN FRANCISCO and SAN DIEGO, April 17, 2023 (GLOBE NEWSWIRE) — Kinnate Biopharma Inc. (Nasdaq: KNTE) (Kinnate), a clinical-stage precision oncology company, today announced positive monotherapy dose escalation data for its …
MatTek and NEXT Oncology Announce Licensing Agreement
The Boston-based biotech company will use an inventory of patient-derived cancer cells to develop new lab-grown tumor models to accelerate and refine oncology research, and provide more targeted treatments for …